A recent report states that the global cannabis beverages market size is expected to reach $2.8 Billion by 2025 at a CAGR of 17.8 percent. The report by Grand View Research looked at alcoholic and non-alcoholic beverages using either Cannabidiol (CBD) and Tetrahydrocannabinol (THC).
“By component, the market is segmented into Cannabidiol (CBD) and Tetrahydrocannabinol (THC). The demand of THC infused cannabis beverages is majorly driven by rising product demand from adult consumers for recreational purposes,” the report states. “Rising demand for the therapeutic effects of the component along with the euphoria it provides is expected to bode well for the growth of the segment in the forthcoming years.”
I contrast, the CBD infused cannabis drinks are registered the fastest growth in (prior years). Also, the demand is expected to witness a surge over the forecasted period owing to the non-psychoactive properties of CBD, according to the report. Lack of psychoactive effect in the CBD drinks is widening its scope for usage of the drinks in medical purposes.
Many consumers are considering CBD drinks as a wellness and anti-inflammatory products, such as kombucha-a probiotic drink. This drink can potentially be used for treating chronic pain, anxiety, substance use disorders and central nervous system diseases. These factors are expected to boost the adoption of the product, resulting in the growth of the segment.”